LSAT 101 – Section 3 – Question 06

LSAT 101 - Section 3 - Question 06

December 1997

You need a full course to see this video. Enroll now and get started in less than a minute.

Request new explanation

Target time: 1:14

This is question data from the 7Sage LSAT Scorer. You can score your LSATs, track your results, and analyze your performance with pretty charts and vital statistics - all with a Free Account ← sign up in less than 10 seconds

Question
QuickView		 Type Tags Answer
Choices		 Curve Question
Difficulty		 Psg/Game/S
Difficulty		 Explanation
PT101 S3 Q06
+LR
Weaken +Weak
Causal Reasoning +CausR
Sampling +Smpl
Value Judgment +ValJudg
A
0%
164
B
2%
162
C
1%
160
D
96%
168
E
1%
156
120
129
142
 +Easiest 146.901 +SubsectionMedium

Asthmagon was long considered the most effective of the drugs known as beta-2 agonists, designed to alleviate asthma attacks. However, studies conducted in Rhiago between 1981 and 1987 revealed that nearly one out of every five of the asthma patients under observation who took asthmagon suffered serious side effects after taking the drug. Citing this statistic, some doctors argue that asthmagon should be banned as an anti-asthma drug.

Summarize Argument
Some doctors argue that asthmagon should be banned for asthma patients. Their support is that 20% of asthma patients suffered serious side effects from asthmagon during studies.

Notable Assumptions
The doctors assume that asthmagon should be banned based on its side effects. This means that they believe the serious side effects outweigh any potential benefits that asthmagon affords asthma patients. The doctors also assume that asthmagon hasn’t changed as a drug since these studies were undertaken, and that the studies weren’t compromised by some external factor.

A
In Rhiago, where asthmagon had been the most widely prescribed of the beta-2 agonists, the number of asthma deaths increased between 1981 and 1987.
If asthma deaths increased in an area where asthmagon was prescribed, that suggests the drug isn’t working all that well. This certainly doesn’t weaken the claim that asthmagon should be banned.
B
Many of the patients under observation to whom asthmagon was administered had not previously taken a beta-2 agonist.
Regardless of what the patients had previously taken, asthmagon had serious side effects. That alone, at least for the doctors, is enough to ban it. This doesn’t weaken that claim.
C
Despite the growing concern about the drug, many physicians in Rhiago still prescribe asthmagon to asthma sufferers.
We don’t care what doctors do. We care about whether or not asthmagon should be banned because of its side effects.
D
Among the patients observed, only those who had very high cholesterol counts suffered side effects after taking asthmagon.
Asthmagon does cause side effects, but only for a certain subset of patients. It doesn’t follow to ban asthmagon for everyone, which is what the doctors are recommending.
E
Asthmagon increases the severity of asthma attacks in some people because the drug can cause damage to heart tissues.
This is yet another reason to ban asthmagon. We’re looking for an answer that weakens the doctors’ stance.

Take PrepTest

Review Results

LSAT PrepTest 101 Explanations

Section 1 - Reading Comprehension

Section 2 - Logical Reasoning

Section 3 - Logical Reasoning

Section 4 - Reading Comprehension

Get full LSAT course

Leave a Reply